Q301--FY27 Cxbladder Molecular Diagnostic Testing
VETERANS AFFAIRS, DEPARTMENT OF · VETERANS AFFAIRS, DEPARTMENT OF · 248-NETWORK CONTRACT OFFICE 8 (36C248)
- Response Deadline
- 2026-11-23 (0d left)
- Location
- TAMPA, FL Buying office: FL; work location not supplied
- Solicitation / Notice ID
- 36C24827Q0133 · NoticeId: 3dbd335867b84d72ae86df00d478dda7
- Primary Contact
- Keila Presidentkeila.president@va.govN/A
Scope Summary (Sanitized Plain Text from SAM.gov)
The Department of Veterans Affairs, James A. Haley VA Medical Center s (JAHVAMC) intent to solicit sole source to Pacific Edge Diagnostics USA Ltd., for specialized reference laboratory services for Cxbladder molecular diagnostic testing. 1.OBJECTIVE: 1.1 JAHVAMC requires Cxbladder testing for patients with suspected urothelial carcinoma, a history of urothelial carcinoma, or urinary tract abnormalities that cannot be definitively classified by routine morphologic evaluation alone. Cxbladder testing evaluates urinary messenger RNA (mRNA) biomarkers associated with urothelial carcinoma and provides clinically relevant molecular information to support diagnostic clarification, risk stratification, surveillance, and informed treatment decisions. JAHVAMC seeks a firm fixed-price, cost-per-test contract consisting of one 12-month base period and four 12-month option periods. The Contractor shall furnish Cxbladder Triage® and Cxbladder Monitor® testing, including all required test kits, collection and shipping materials, specimen transportation, laboratory analysis, result reporting, technical support, and secure electronic access to finalized test results. 2. SCOPE: 2.1 The Contracto…
Source extract: Sun, 22 Nov 2026 04:30:19 GMT. SAM.gov is the sole authoritative legal record. Verify amendments, Q&A, and mandatory site visits on SAM.gov.